Chronic Myelomonocytic Leukemia, IPSS-R vs CPSS in Argentina
CMML is a clonal disorder sharing features of myelodysplastic syndromes (MD) and myeloproliferative (MP) disorders. CMML Prognostic Scoring System (CPSS) was designed specifically for CMML patients. The Revised International Prognostic Scoring System IPSS-R has been also validated to stratify CMML MD. There is no data comparing this scoring systems in our population.
Source: Clinical Lymphoma, Myeloma and Leukemia - Category: Hematology Authors: Maria Agustina Perusini, Natalia Schutz, Jorge Arbelbide Source Type: research
More News: Argentina Health | Chronic Leukemia | Leukemia | Lymphoma | Myelodysplastic Syndrome | Myeloma | Myeloproliferative Disorders